[-] Show simple item record

dc.contributor.authorIbay, Annamarie D.eng
dc.contributor.authorBascelli, Lynda M.eng
dc.contributor.authorNashelsky, Joaneng
dc.date.issued2005-05eng
dc.description.abstractTreatment of subclinical hypothyroidism with levothyroxine may be of most benefit to patients with symptoms suggestive of hypothyroidism and those patients with thyroid-stimulating hormone (TSH) levels higher than 10 μIU per mL (10 mIU per L) or positive anti-thyroid peroxidase (TPO) antibodies. Levothyroxine is recommended for pregnant patients. For asymptomatic patients with TSH levels between 4.5 and 10 μIU per mL (4.5 and 10 mIU per L), treatment may not be beneficial, but their thyroid function should be monitored at six- to 12-month intervals. [Strength of recommendation: C, based on expert opinion and systematic reviews with troublesome heterogeneity of disease-oriented evidence]eng
dc.identifier.citationAmerican Family Physician, 71(9) 2005.eng
dc.identifier.urihttp://hdl.handle.net/10355/3954eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2005 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjecthormone replacementeng
dc.subjectcardiac dysfunctioneng
dc.subjectthyroid-stimulating hormone (TSH)eng
dc.subject.lcshThyroid hormoneseng
dc.subject.lcshHypothyroidismeng
dc.subject.lcshThyroid gland -- Diseaseseng
dc.titleManagement of Subclinical Hypothyroidismeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record